|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.3 TWD | -0.18% |
|
+1.11% | -8.70% |
Intech Biopharm Corporation reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 3.65 million compared to TWD 11.17 million a year ago. Net loss was TWD 81.16 million compared to TWD 69.22 million a year ago.
Basic loss per share from continuing operations was TWD 0.7 compared to TWD 0.6 a year ago. Diluted loss per share from continuing operations was TWD 0.7 compared to TWD 0.6 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.70% | 115M | |
| +5.31% | 70.44B | |
| +10.97% | 8.94B | |
| -16.83% | 4.75B | |
| +43.48% | 4.5B | |
| +3.20% | 3.85B | |
| -21.36% | 2.34B | |
| -29.67% | 2.2B | |
| +8.38% | 1.96B | |
| +3.90% | 1.65B |
INTECH BIOPHARM CORPORATION 
